BFM
RMD icon

Boothbay Fund Management’s ResMed RMD Stock Holding History

Boothbay Fund Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,000
Closed -$2.87M – 1884
2024
Q2 		$2.87M Buy
+15,000
New +$3.04M 0.07% 385

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Boothbay Fund Management's RMD Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in ResMed (RMD) in Q2 2026: 2,444 shares worth $476K. The stake represents 0.01% of the portfolio and ranks #1526 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in RMD as recently as Q4 2023.

Boothbay Fund Management first reported a position in RMD in Q1 2021 and has held it in 12 quarters since. The position peaked at $4.07M in Q1 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Boothbay Fund Management held 2,444 shares of ResMed worth $476K as of Q2 2026.
  • ResMed was a new Boothbay Fund Management position in Q2 2026.
  • ResMed made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1526 holding.
  • Boothbay Fund Management first reported a position in ResMed in Q1 2021 and has held it in 12 quarters since.
  • Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.